Skip to main content
Caplight Logo









Vandria

Vandria

Private
LausanneHealthcare & Life Scienceshttps://vandria.com/

Last Round

Grant

Aug 22, 2024

Total Funding Raised

$71.3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Vandria is a biotechnology company that develops first-in-class small molecule mitophagy inducers to rejuvenate cells and treat age-related and chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalmitophagysmall-molecule therapeuticsdrug discoveryage-related diseaseCNS disordersmitochondrial functionlongevity biotechneurodegenerative diseasepre-clinical pipelinebrain-penetrantbiotech startupdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vandria Comparables

Compare Vandria with similar companies based on industry and business-model similarity.

Vandria comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MitoRx Therapeutics
85%
Endurance Bio Inc.
84%
Morningside
83%

Vandria Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 22, 2024
Series AAug 21, 2024
GrantFeb 8, 2024
Series ADec 14, 2023
SeedSep 1, 2021

Vandria Investors

Notable investors and investment history

Vandria investors
InvestorRounds
Dolby Family VenturesSeries A
+ND CapitalSeries A
Hevolution FoundationSeries A
Eurostars SME programmeGrant
InnosuisseGrant
ND CapitalSeries A, Seed
InnosuisseGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 466% MoM, reaching 2.9K.

  • Feb 8, 2024

    Secured $4M from Eurostars SME programme and Innosuisse.

Recent news

Latest coverage and updates

  • attends_eventJul 23, 2026

    Vandria attends event Alzheimer's Association International Conference.

Vandria Filings

Explore SEC and related filing metadata, where available.

Vandria filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vandria's valuation, stock price, and market status.

Is Vandria a public or private company?

Vandria is a private company.

What is the current stock price of Vandria?

Vandria is a private company with no public stock price. No recent secondary market data is available.

How much is Vandria worth (valuation)?

Valuation information for Vandria is not publicly available.

Can I buy Vandria stock?

Vandria shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vandria's last funding round?

Vandria's most recent funding round was Grant on August 22, 2024.

Who are the main investors in Vandria?

Key investors in Vandria include Dolby Family Ventures, +ND Capital.

Will Vandria IPO soon?

No public IPO plans have been announced for Vandria.

How can I track Vandria secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vandria's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLausanne
Employee Range14
Year Founded2021
Last FundingAug 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?